New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 4, 2013
15:09 EDTHIG, EW, YUM, LIFE, GILD, TMK, LEG, APCCompanies reporting After the Market Close on Monday, February 4
Notable companies reporting after the bell include Anadarko Petroleum (APC), Gilead Sciences (GILD), Edwards Lifesciences (EW), Leggett & Platt (LEG), Life Technologies (LIFE), The Hartford Financial Services Group (HIG), Torchmark (TMK) and Yum! Brands (YUM).
News For APC;GILD;EW;LEG;LIFE;HIG;TMK;YUM From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
November 11, 2014
08:07 EDTGILDGilead announces results from Phase 2 and 3 studies evaluating Harvoni
Subscribe for More Information
08:05 EDTGILDGilead announces data from Phase 2 Sofosbuvir plus GS-5816 studies
Subscribe for More Information
November 10, 2014
16:00 EDTGILDOptions Update; November 10, 2014
Subscribe for More Information
15:43 EDTAPCAmerican Petroleum Institute to hold a conference
Subscribe for More Information
09:35 EDTGILDActive equity options trading
Subscribe for More Information
09:20 EDTGILDOn The Fly: Pre-market Movers
Subscribe for More Information
08:48 EDTGILDGilead rises after Merck presents data on HCV combo
Subscribe for More Information
07:36 EDTYUMPizza Hut to unveil major menu expansion, CNBC reports
Subscribe for More Information
07:20 EDTGILDGilead overhang from Merck HCV combo removed, says Wells Fargo
Subscribe for More Information
07:08 EDTHIGCredit Suisse to hold a conference
2014 Boston Financials 1:1 Conference to be held in Boston on November 10-11.
November 7, 2014
10:00 EDTEWOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
09:36 EDTGILDActive equity options trading
Active equity options trading according to Track Data: AAPL WFM ABX GILD TSLA ZNGA FB FSLR GOOG AMZN
07:43 EDTGILDGilead Harvoni prescriptions trending well above Sovaldi, says RBC Capital
Subscribe for More Information
06:44 EDTEWEdwards Lifesciences downgraded to Neutral from Buy at Sterne Agee
Subscribe for More Information
November 6, 2014
16:00 EDTGILDOptions Update; November 6, 2014
Subscribe for More Information
15:13 EDTGILDAmerican Association for Study of Liver Diseases to hold a meeting
Subscribe for More Information
12:20 EDTGILDStocks with call strike movement; RIG GILD
Transocean (RIG) February 33 call option implied volatility decreased 7% to 42, Gilead (GILD) May 130 call option implied volatility increased 2% to 38 according to IVolatility.
09:40 EDTGILDActive equity options trading
Subscribe for More Information
08:39 EDTGILDGilead submits NDA to FDA for elvitegravir, emtricitabine, tenofovir alafenamid
Gilead Sciences announced that it has submitted a New Drug Application to the U.S. Food and Drug Administration for an investigational, once-daily single tablet regimen containing elvitegravir 150 mg, cobicistat 150 mg, emtricitabine 200 mg and tenofovir alafenamide 10 mg for the treatment of HIV-1 infection in adults. The data submitted in the NDA support the use of the regimen among adult and adolescent treatment-na´ve HIV individuals, virologically suppressed patients who switch regimens and those with renal impairment. Gilead plans to submit a regulatory application for E/C/F/TAF in the European Union by the end of 2014.
07:41 EDTHIGExecutives' Club of Chicago to hold a luncheon meeting
Subscribe for More Information
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use